JPM 2025 Wrap: Sunny Skies & Megarounds

Deal flow and the lure of Asian innovation counterbalance continued capital markets gloom as biotech kicks off the New Year in San Francisco

Sunshine and a stream of deals brightened the mood at this year’s J.P. Morgan Healthcare Conference, offering a pleasant counterpoint to continued pessimism over the state of the capital markets. On the latest BioCentury This Week podcast, BioCentury’s editors deliver their takeaways from biotech’s annual kick-off event from megarounds and Asian newcos to the new state of M&A and pending change at FDA.